Find out about all the innovative features of
MonCvONE-CR, Metrovision's multimodal
vision testing equipment!
METROVISION's products are manufactured under the most stringent quality control conditions and registered in many countries
CertificationsClick here to contact us
Informations
Metrovision has reached a new regulatory milestone with the certification of its Vision Monitor range under
the European Medical Device Regulation (EU) 2017/745 (MDR).
This achievement reflects Metrovision’s ongoing commitment to the quality, safety and performance of its medical devices..
Many studies have been published or presented in 2024 using Metrovision's equipments.
Their list is available from the following link:
ESCRS meeting - Booth E.320
Click here for more informationSeminar of Vision Monitor users (in French)
Click here for more informationEuropean Paediatric Ophthalmology Society
Click here for more informationEuretina meeting - Booth F12
Click here for more informationSeminar of Vision Monitor users (in English)
Click here for more information
Discover the applications of the Vision Monitor on the YouTube channel:
Click here for more information
The ability to adapt to low and high levels of light is important for the evaluation of visual aptitudes and as an outcome of clinical trials. Metrovision has completed its "classic" dark adaptometry test with a test of full field stimulus threshold (FST) and a test of photoaversion threshold (PAT). These tests complement the chromatic perimetry tests already available on the MonCvONE-CR system.
More information on dark and light adaptometry
Metrovision has received US-FDA clearance for its MonCvONE and MonPackONE
products including vision electrophysiology and vision psychophysics applications.
MonPackONE can be combined with MonCvONE, creating the most advanced multimodal platform for visual function analysis.
